Ace:
News
Research
Recommended approval for Leqembi in the early treatment of Alzheimer's disease
15/11/2024
The European Medicines Agency (EMA) has recommended the authorisation of Leqembi for the treatment of Alzheimer's disease.
TARTAGLIA receives an honourable mention in the National Health Informatics Awards 2025
03/02/2025Research
BLOG | 30 years helping families and carers
30/01/2025Day care and treatment
Lewy body dementia: a dementia requiring early and specialised diagnosis
28/01/2025Diagnosis
Ace Alzheimer Center Barcelona participates in the Alzheimer's Association International Conference® Neuroscience Next
23/01/2025Research
Paris 70: a short film about Alzheimer's disease nominated for the Goya Awards and finalist for the Oscar Awards
21/01/2025Awareness